Jiayang Wu

Jiayang Wu

Auto-generated profile, based on publicly available information

Jiayang Wu

Department of Radiology University of California San Diego, La Jolla California USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
QDQiu Dong
Qiu Dong
JWJiayang Wu
Jiayang Wu
HZHuaguo Zhang
Huaguo Zhang
XCXinhui Chen
Xinhui Chen
XXXi Xu
Xi Xu
DZDong Zhang
Dong Zhang
Purpose: Immunometabolism is pivotal in rheumatoid arthritis (RA) pathogenesis, yet the intricacies of its pathological regulatory mechanisms remain poorly understood. This study explores the complex immunometabolic landscape of RA to identify potential therapeutic targets. Patients and Methods: We integrated genome-wide association study (GWAS) data involving 1,400 plasma metabolites, 731 immune cell traits, and RA outcomes from over 58,000 participants. Mendelian randomization (MR) and mediation analyses were applied to evaluate causal relationships among plasma metabolites, immune cells, and RA. We further analyzed single-cell and bulk transcriptomes to investigate differential gene expression, immune cell interactions, and relevant biological processes. Machine learning models identified hub genes, which were validated via quantitative real-time PCR (qRT-PCR). Then, potential small-molecule drugs were screened using the Connectivity Map (CMAP) and molecular docking. Finally, a phenome-wide association study (PheWAS) was conducted to evaluate potential side effects of drugs targeting the hub genes. Results: Causalities were found between six plasma metabolites, five immune cells and RA in genetically determined levels. Notably, DC mediated 18% of the protective effect of PE on RA. Autophagy-related scores were elevated in both RA and DC subsets in PE-associated biological processes. Through observation in the functional differences in cellular interactions between the identified clusters, DCs with high autophagy scores may process such as necroptosis and the activation of the Jak-STAT signaling pathway in contributing the pathogenesis of RA. Explainable machine learning, PPI network analysis, and qPCR jointly identified four hub genes (PFN1, SRP14, S100A11, and SAP18). CMAP, molecular docking, and PheWAS analysis further highlighted vismodegib as a promising therapeutic candidate. Conclusion: This study clarifies the key immunometabolic mechanisms in RA, pinpointing promising paths for better prevention, diagnosis, and treatment.

21 October 2026 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
JWJiayang Wu
Jiayang Wu
DMDina Moazamian
Dina Moazamian
DKDonghyun Kim
Donghyun Kim
JWJiaji Wang
Jiaji Wang
MCMohamad Amin Cheraghi
Mohamad Amin Cheraghi
Jiang DuJiang Du
Jiang Du
Background: ACLR is associated with altered joint loading and increased risk of post‐traumatic osteoarthritis. Conventional MRI has limited sensitivity to early meniscal differences because of short‐T2 signal decay and magic‐angle effects. Purpose: To evaluate whether 3D ultrashort echo time imaging‐based adiabatic T1rho (UTE‐Adiab‐T1rho) and ultrashort echo time imaging‐based macromolecular fraction (UTE‐MMF) identify regional quantitative MRI differences after ACLR. Study Type: Prospective longitudinal cohort study. Population: 30 control scans, 19 ACLR scans at 6–12 months, and 13 ACLR scans at 12+ months were analyzed. Mean ages were 34.5, 34.5, and 37.2 years; female/male counts were 15/15, 9/10, and 8/5. Field Strength/Sequence: Participants underwent 3‐T knee MRI with 3D fat‐saturated UTE‐Adiab‐T1rho and UTE magnetization transfer sequences. Assessment: UTE‐Adiab‐T1rho and UTE‐MMF maps were generated with single‐component exponential and two‐pool magnetization transfer models. Values were extracted from four meniscal regions of interest by a blinded reader, with blinded redelineation in a subset. Patient‐reported outcomes included International Knee Documentation Committee, Knee Injury and Osteoarthritis Outcome Score, and Western Ontario and McMaster Universities Osteoarthritis Index scores. Statistical Tests: Linear mixed‐effects models accounted for repeated observations. Benjamini‐Hochberg FDR correction was applied. Results: UTE‐Adiab‐T1rho showed significant group ( q = 0.001) and region ( q < 0.001) effects. Compared with controls, UTE‐Adiab‐T1rho was higher in LAM at 6–12 months (+5.60 ms; q = 0.035) and 12+ months (+7.09 ms; q = 0.028), and in LPM at 12+ months (+6.35 ms; q = 0.035). UTE‐MMF showed significant group ( q = 0.041) and region ( q < 0.001) effects. LPM UTE‐MMF was lower than controls at 6–12 months (−3.56 percentage points; q = 0.028) and 12+ months (−3.10 percentage points; q = 0.049). No 6–12 versus 12+ month MRI or PROM contrast survived FDR correction. MRI‐PROM associations were not FDR‐significant (all q ≥ 0.383). Data Conclusion: UTE‐Adiab‐T1rho and UTE‐MMF mapping identified regional MRI differences after ACLR. Pairwise differences were concentrated in lateral regions, but corrected group‐by‐region interactions were not significant. PROMs were worse after ACLR but did not differ between postoperative windows after correction. Evidence Level: 2. Technical Efficacy Stage: 2.

23 September 2025 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
HZHuaguo Zhang
Huaguo Zhang
DHDahai Hu
Dahai Hu
JWJiayang Wu
Jiayang Wu
QTQiang Teng
Qiang Teng
CZCuiwen Zhang
Cuiwen Zhang
XZXing Zhong
Xing Zhong